Is Ritalin As Effective--And As Harmless--As It Could Be?

DALLAS, March 29 -- Ritalin, the treatment of choice for an estimated 2 million or more children suffering from attention deficit hyperactivity disorder, could be more effective and cause fewer side-effects if it were administered as a single compound rather than as a mixture, say chemists at Brookhaven National Laboratory. Yu-Shin Ding, Ph.D., and colleagues presented their findings here today at the national meeting of the American Chemical Society, world's largest scientific society.

Methylphenidate (marketed as Ritalin) is a chiral drug, meaning that it comes in two molecular forms, one a mirror image of the other (enantiomers). Currently Ritalin, which topped $350 million in sales last year, said Ding, is distributed as a "racemic" mixture of both its chiral molecules -- d-threo and l-threo.

However, some evidence has suggested that the drug's therapeutic effect resides solely in the d-threo enantiomer, which is about 10 times more potent than its chiral counterpart, according to Ding. "If the beneficial effects of the drug reside only in the d-threo form," she said, "then fifty percent of the weight of the administered drug may not contribute to its therapeutic effects."

Ding, along with colleagues Joanna S. Fowler and Nora Volkow, studied the individual effects of d-threo and l-threo on the central nervous system. They tagged each enantiomer with a short-lived radioactive tracer chemical -- calleda carbon-11 isotope -- with a half-life of 20 minutes. They then used positron emission tomography (PET) to compare the enantiomers' effects in the brains of baboons and humans. (Radiotracers emit signals as they decay that can be collected by a PET scan to generate images.) The study showed that the d-threo enantiomer bound precisely to the dopamine targets in the brain, while the binding of l-threo was mostly non-specific.

What's more, Ding says, the l-threo enantiomer may ha

Contact: Jim Bohning
American Chemical Society

Page: 1 2

Related medicine news :

1. New studies on Ritalin and Alzheimers Disease highlight ACNP Annual Meeting
2. Study reveals differences in patients response to Ritalin
3. Ritalin helps children with ADHD maintain normal reaction time
4. Ritalin and Prozac: Study finds more kids using both drug types together
5. Boys treated with Ritalin, other stimulants significantly less likely to abuse drugs later
6. First Trial Comparing Adderall To Ritalin For ADHD Shows It To Be Longer-Lasting, Equally As Effective
7. Improved Ritalin Offers Smaller Doses And Fewer Side Effects
8. New Theory May Explain Ritalin Action In Hyperactivity
9. How Ritalin Enhances Memory: Clues Provided By Brain Scans of ADHD Patients Using The Drug
10. Could skin cells become brain cells?
11. Could autoantibodies predict future disease in healthy people?

Post Your Comments:
TAG: Ritalin Effective And Harmless Could

(Date:10/8/2015)... ... October 08, 2015 , ... Mirixa Corporation ... decade as the recognized leader in targeted patient care services, Mirixa remains dedicated ... community pharmacies available. Recent changes in the health care marketplace threaten to limit ...
(Date:10/8/2015)... ... October 08, 2015 , ... Daniel S. Herman, ... a Life Fellow by the Healthcare Information and Management Systems Society (LFHIMSS) for ... technology. The HIMSS Board of Directors advances members to this status who have ...
(Date:10/8/2015)... ... October 08, 2015 , ... Nachos, wings and beer are a ... snack selection at your weekend football gathering. , Registered dietitians from Retrofit, a ... be a football foodie while keeping your health in the game. , Have ...
(Date:10/8/2015)... ... 08, 2015 , ... Carpet One Floor & Home has just released their ... One Welcomes Your Support campaign has been raising funds to support organizations and researchers ... , Twenty-five percent of each sale will be donated to the Breast Cancer ...
(Date:10/8/2015)... ... October 08, 2015 , ... HIMSS will dig deep into one of ... and Healthcare Analytics Forum , to be held at the Westin Copley Place in ... School and David W. Bates, CIO and SVP of Brigham and Women’s Hospital, as ...
Breaking Medicine News(10 mins):
(Date:10/8/2015)... Oct. 8, 2015  A new series of videos ... by Janssen Research & Development, LLC ("Janssen") as part ... about progress in brain research, treatment options, and resources ... and communities. The new videos can be viewed on ... Mary Giliberti , J.D., Executive Director at the ...
(Date:10/8/2015)... 8, 2015 USA ... Chief Commercial Officer wird Groch für die Leitung ... verantwortlich zeichnen, die mit der Einführung von ... mit nicht muskelinvasivem Blasenkrebs nach deren voraussichtlichen Zulassung ... 1. Quartal 2016 ihren Anfang nehmen wird. --> ...
(Date:10/8/2015)... N.J. , Oct. 8, 2015 "Official Joint ... Orthopaedics heads to Cary, NC this ... 15 th anniversary and known as one of the ... is pleased to bring the Stryker Mobility Zone to SAS ... year. Bill Huffnagle , President, Reconstructive Division, ...
Breaking Medicine Technology:
Cached News: